Imprint Wealth LLC acquired a new position in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 297 shares of the semiconductor company’s stock, valued at approximately $249,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of LRCX. Orion Capital Management LLC acquired a new stake in Lam Research during the third quarter worth about $25,000. BluePath Capital Management LLC acquired a new stake in shares of Lam Research during the third quarter valued at about $28,000. OFI Invest Asset Management acquired a new stake in shares of Lam Research during the third quarter valued at about $30,000. Asset Dedication LLC increased its position in shares of Lam Research by 56.7% during the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock valued at $30,000 after acquiring an additional 17 shares during the last quarter. Finally, Valued Wealth Advisors LLC acquired a new stake in shares of Lam Research during the fourth quarter valued at about $30,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Lam Research
In other news, Director Abhijit Y. Talwalkar sold 882 shares of the company’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $972.03, for a total transaction of $857,330.46. Following the transaction, the director now directly owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, SVP Seshasayee Varadarajan sold 5,500 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the transaction, the senior vice president now directly owns 22,095 shares of the company’s stock, valued at approximately $20,380,648.95. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Abhijit Y. Talwalkar sold 882 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the sale, the director now owns 10,541 shares in the company, valued at $10,246,168.23. The disclosure for this sale can be found here. Insiders have sold a total of 7,029 shares of company stock valued at $6,559,489 in the last ninety days. 0.32% of the stock is currently owned by company insiders.
Lam Research Stock Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its quarterly earnings data on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.06 by $0.46. The company had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.71 billion. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. Lam Research’s revenue was down 28.8% compared to the same quarter last year. During the same period in the previous year, the company posted $10.71 EPS. On average, sell-side analysts predict that Lam Research Co. will post 28.9 earnings per share for the current year.
Lam Research Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 3rd. Shareholders of record on Wednesday, March 13th were paid a $2.00 dividend. The ex-dividend date of this dividend was Tuesday, March 12th. This represents a $8.00 annualized dividend and a yield of 0.83%. Lam Research’s dividend payout ratio is currently 30.94%.
Wall Street Analyst Weigh In
LRCX has been the subject of a number of recent analyst reports. UBS Group lifted their price target on shares of Lam Research from $885.00 to $1,130.00 and gave the company a “buy” rating in a research report on Tuesday, March 5th. Mizuho lifted their price target on shares of Lam Research from $900.00 to $935.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. Barclays lifted their price target on shares of Lam Research from $750.00 to $825.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Wells Fargo & Company lifted their price target on shares of Lam Research from $930.00 to $980.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 2nd. Finally, Stifel Nicolaus lifted their price target on shares of Lam Research from $950.00 to $1,050.00 and gave the stock a “buy” rating in a research note on Tuesday. Eight research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $875.55.
Check Out Our Latest Stock Report on Lam Research
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Recommended Stories
- Five stocks we like better than Lam Research
- How to Find Undervalued Stocks
- Prologis Stock Leading U.S. Logistics Boom
- What is the Euro STOXX 50 Index?
- Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Are We in a Bull Market? 4 Factors that Determine a Bull Market
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.